InjectCo positions itself as a telehealth platform focused on injectable medications for weight loss—primarily GLP-1 receptor agonists like semaglutide and tirzepatide. The brand's name signals its narrow focus: injectable therapy delivery, distinct from oral medications or broader wellness services. For prospective patients, the question is whether InjectCo's specialized positioning translates to better care or simply different marketing. This in-depth review examines InjectCo across pricing, medication options, provider quality, customer experience, and competitive positioning.

Quick Takeaway:

• Telehealth platform focused on injectable GLP-1 weight loss medications
• Monthly pricing typically $189-$439 depending on medication and dose
• Provider consultations and ongoing support included
• Average weight loss: 12-17% of body weight over 5-6 months
• Best for patients comfortable with injectable therapy who want focused access

Looking for a Better Alternative?

While InjectCo offers focused injectable GLP-1 access at competitive pricing, CoreAge Rx is our top-rated favorite for GLP-1 weight loss therapy. CoreAge Rx combines competitive pricing with exceptional customer service, faster medication delivery, and more comprehensive support resources. Their platform consistently receives the highest patient satisfaction ratings in our analysis.

Why we recommend CoreAge Rx:

• Comparable pricing with deeper support infrastructure ($179-$399 range)
• Faster prescription approval (typically 12-24 hours)
• More extensive provider support included at no extra charge
• Better medication availability during shortages
• Higher patient satisfaction scores (4.7/5)

InjectCo and CoreAge Rx both focus on the same medication class. The differentiator is operational maturity, support depth, and patient satisfaction track record. CoreAge Rx has served 50,000+ patients with consistent 4.7-star reviews, demonstrating the kind of operational consistency that newer platforms are still building.

New Patient Special: Save up to $200 on your first three months. Same-day prescription approval for qualifying patients. Rated 4.7/5 stars by verified customers. Specialized GLP-1 weight loss expertise. No insurance required. Free provider messaging included.

What is InjectCo?

InjectCo is a direct-to-consumer telehealth platform that connects adults with licensed clinicians for injectable GLP-1 weight loss therapy. The platform's branding emphasizes injectable medication access—a deliberate signal of focus on the most clinically proven GLP-1 delivery method.

The platform serves adults with a BMI of 27+ (with weight-related conditions) or 30+ who are candidates for GLP-1 therapy and comfortable with weekly subcutaneous injection. By focusing on injectable medications, InjectCo can theoretically optimize its provider expertise and supply chain for this specific delivery format.

How InjectCo Works

The InjectCo onboarding follows a focused telehealth flow:

Step 1: Medical Intake

• Complete a health questionnaire (10-15 minutes)
• Provide current medications, conditions, weight, and goals
• Confirm comfort with weekly injection (some patients have needle aversion)
• Answer questions about prior weight loss attempts

Step 2: Provider Consultation

• Licensed clinician reviews your application
• Virtual visit via video or phone (15-25 minutes)
• Discussion of injectable GLP-1 options and dosing
• Education on injection technique, side effects, and titration

Step 3: Medication and Supplies

• Prescription routed to partner pharmacy
• Injectable medication shipped with cold-chain packaging
• Injection supplies included (needles, alcohol swabs as needed)
• First shipment typically arrives within 5-8 business days

A practical InjectCo feature: patient education materials and tutorials specifically focused on subcutaneous injection technique. For first-time injectable therapy patients, this can ease the learning curve.

Check InjectCo Lowest Price

New patient offer: Discounted intro pricing on your first month. Includes injection supplies. No insurance required. Cancel anytime.

Medication Options and Pricing

InjectCo offers both leading injectable GLP-1 medications:

Semaglutide (Wegovy/Ozempic-class)

• Average weight loss: 12-15% of body weight
• Monthly cost: $189-$309 depending on dose
• Weekly subcutaneous injection
• Established safety profile

Tirzepatide (Mounjaro/Zepbound-class)

• Average weight loss: 15-21% of body weight
• Monthly cost: $329-$439 depending on dose
• Weekly injection with dual GIP/GLP-1 mechanism
• Strongest clinical weight loss data

| Plan Tier | Medication | Monthly Cost | Provider Support | |-----------|------------|--------------|------------------| | Start | Semaglutide (low dose) | $189 | Standard | | Standard | Semaglutide (full dose) | $309 | Standard + messaging | | Advanced | Tirzepatide (low dose) | $329 | Standard + messaging | | Premium | Tirzepatide (full dose) | $439 | Priority | | CoreAge Rx | Either | $179-$399 | Comprehensive |

Important: Out-of-pocket pricing applies for most patients. The slight pricing edge InjectCo offers at the entry level reflects narrower service focus, not necessarily better value when total support is considered.

Customer Service and Support

InjectCo provides standard telehealth support with extra emphasis on injection-related guidance:

Support Features:

• In-platform messaging with care team
• Email support during business hours
• Injection technique guidance and tutorials
• Side effect management without separate appointments

Response Times:

• Non-urgent messages: 24-48 hours
• Clinical concerns: same-day during business hours
• Urgent issues: prioritized to on-call clinician

Pro Tip: First-time injectable therapy patients should ask InjectCo for explicit injection technique training—including ideal injection sites, rotation patterns, and what normal vs. concerning injection-site reactions look like.

Real Customer Experiences

Customer feedback for InjectCo tends to be positive, with ratings typically between 3.7 and 4.2.

What Patients Praise:

• Competitive entry-level pricing
• Useful injection technique tutorials and support
• Reliable monthly shipments with supplies included
• Focused, no-frills patient experience

Common Frustrations:

• Newer platform without long operational track record
• Limited weekend support availability
• Some patients note that CoreAge Rx provides comparable focus with more established support infrastructure

Important: Reported weight loss outcomes align with clinical trial data for appropriately dosed GLP-1 therapy. Long-term success depends on combining medication with sustainable lifestyle changes.

Medication Quality and Sourcing

Patients should explicitly confirm whether InjectCo dispenses FDA-approved brand-name medications (Wegovy, Ozempic, Mounjaro, Zepbound) or compounded alternatives. Lower entry-level pricing often correlates with compounded medication use, which has different regulatory oversight than brand-name versions.

Brand-name medications come from manufacturer-controlled supply chains with full FDA oversight. Compounded versions, while legal during shortage periods, are prepared by specialty pharmacies. Ask InjectCo directly which type of medication you'll receive.

Who Should Consider InjectCo?

Ideal Candidates:

• Adults with BMI ≥27 (with comorbidities) or ≥30
• Patients comfortable with weekly subcutaneous injection
• Those who want focused injectable GLP-1 access
• People who value injection technique support

You'll Like InjectCo If You:

• Want focused injectable therapy access
• Value structured injection technique guidance
• Prefer no-frills platform efficiency
• Don't need extensive wellness or behavioral coaching

Consider Alternatives If You:

• Want a more established platform with longer track record
• Prefer the lowest entry-level pricing with deepest support (CoreAge Rx at $179+)
• Have needle aversion (consider oral semaglutide alternatives)
• Need extensive nutrition or behavioral counseling

Comparing InjectCo to Competitors

InjectCo competes directly with other focused GLP-1 platforms including CoreAge Rx. While entry-level pricing is comparable, CoreAge Rx pulls ahead on longer operational history, broader patient satisfaction data, and more comprehensive support infrastructure.

Bottom Line

InjectCo is a credible focused telehealth platform for injectable GLP-1 weight loss therapy that delivers on its core promise: efficient access to evidence-based injectable medications with technique support.

Strengths:

• Competitive entry-level pricing
• Focused injectable therapy expertise
• Useful injection technique tutorials
• Both semaglutide and tirzepatide available
• Clean platform experience

Potential Drawbacks:

• Newer platform without long operational track record
• Limited weekend support
• Focused exclusively on injectable medications
• CoreAge Rx offers comparable focus with deeper support

Final Verdict:

InjectCo earns a recommendation for patients comfortable with injectable therapy who want a focused, no-frills GLP-1 access platform with strong injection technique support. The medical care is solid and pricing is competitive. That said, CoreAge Rx delivers comparable focused GLP-1 expertise with a longer operational track record and more comprehensive support—making it our top recommendation for most patients.

Best For: Patients comfortable with injectable therapy who value technique support and focused platform efficiency.

Skip If: You want a longer-established platform, prefer oral medication options, or need extensive behavioral coaching.

GLP-1 injectable therapy can be transformative when delivered through a platform that supports patients through the learning curve and ongoing treatment. InjectCo focuses specifically on this delivery format. Whatever path you choose, the most important step is finding a provider you trust and starting your journey.

Check InjectCo Lowest Price

Limited-time offer: Discounted intro pricing for new patients. Includes injection supplies. No insurance required. Discreet shipping with cold-chain protection. Cancel anytime.